172 related articles for article (PubMed ID: 2786039)
1. Decreased number and function of antigen-presenting cells in the skin following application of irritant agents: relevance for skin cancer?
Lisby S; Baadsgaard O; Cooper KD; Vejlsgaard GL
J Invest Dermatol; 1989 Jun; 92(6):842-7. PubMed ID: 2786039
[TBL] [Abstract][Full Text] [Related]
2. Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation.
Cooper KD; Neises GR; Katz SI
J Invest Dermatol; 1986 Apr; 86(4):363-70. PubMed ID: 2943821
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous T-cell lymphoma lesional epidermal cells activate autologous CD4+ T lymphocytes: involvement of both CD1+OKM5+ and CD1+OKM5- antigen-presenting cells.
Hansen ER; Baadsgaard O; Lisby S; Cooper KD; Thomsen K; Vejlsgaard GL
J Invest Dermatol; 1990 Apr; 94(4):485-91. PubMed ID: 1968933
[TBL] [Abstract][Full Text] [Related]
4. Expression of OKM5 antigen on epidermal cells in mycosis fungoides plaque stage.
Lisby S; Baadsgaard O; Cooper KD; Thomsen K; Wantzin GR
J Invest Dermatol; 1988 May; 90(5):716-9. PubMed ID: 2452212
[TBL] [Abstract][Full Text] [Related]
5. Antigen-presenting activity of non-Langerhans epidermal cells in contact hypersensitivity reactions.
Baadsgaard O; Lisby S; Avnstorp C; Clemmensen O; Lange-Vejlsgaard G
Scand J Immunol; 1990 Sep; 32(3):217-24. PubMed ID: 1698306
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis.
Cooper KD; Baadsgaard O; Ellis CN; Duell E; Voorhees JJ
J Invest Dermatol; 1990 May; 94(5):649-56. PubMed ID: 2324521
[TBL] [Abstract][Full Text] [Related]
7. Differential patterns of epidermal leukocyte infiltration in patch test reactions to structurally unrelated chemical irritants.
Willis CM; Stephens CJ; Wilkinson JD
J Invest Dermatol; 1993 Sep; 101(3):364-70. PubMed ID: 8370975
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
Ashworth J; Kahan MC; Breathnach SM
J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
[TBL] [Abstract][Full Text] [Related]
9. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells.
Baadsgaard O; Gupta AK; Taylor RS; Ellis CN; Voorhees JJ; Cooper KD
J Invest Dermatol; 1989 Feb; 92(2):190-5. PubMed ID: 2645367
[TBL] [Abstract][Full Text] [Related]
10. Increases in human epidermal DR+CD1+, DR+CD1-CD36+, and DR-CD3+ cells in allergic versus irritant patch test responses.
Gerberick GF; Rheins LA; Ryan CA; Ridder GM; Haren M; Miller C; Oelrich DM; von Bargen E
J Invest Dermatol; 1994 Oct; 103(4):524-9. PubMed ID: 7523531
[TBL] [Abstract][Full Text] [Related]
11. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin.
Ashworth J; Booker J; Breathnach SM
Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268
[TBL] [Abstract][Full Text] [Related]
12. Phenotype, ultrastructure, and function of CD1+DR+ epidermal cells that express CD36 (OKM5) in cutaneous T-cell lymphoma.
Lisby S; Baadsgaard O; Cooper KD; Hansen ER; Mehregan D; Thomsen K; Allen E; Lange Vejlsgaard G
Scand J Immunol; 1990 Aug; 32(2):111-9. PubMed ID: 1697095
[TBL] [Abstract][Full Text] [Related]
13. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.
Breathnach SM; Shimada S; Kovac Z; Katz SI
J Invest Dermatol; 1986 Mar; 86(3):226-34. PubMed ID: 2427602
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
[TBL] [Abstract][Full Text] [Related]
15. UVB and UVC, but not UVA, potently induce the appearance of T6- DR+ antigen-presenting cells in human epidermis.
Baadsgaard O; Wulf HC; Wantzin GL; Cooper KD
J Invest Dermatol; 1987 Jul; 89(1):113-8. PubMed ID: 3598201
[TBL] [Abstract][Full Text] [Related]
16. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells.
Prens EP; Benne K; van Joost T; Benner R
J Invest Dermatol; 1991 Jun; 96(6):880-7. PubMed ID: 1710638
[TBL] [Abstract][Full Text] [Related]
17. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
Ashworth J; Kahan MC; Breathnach SM
Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
[TBL] [Abstract][Full Text] [Related]
18. Dose response and time course for induction of T6- DR+ human epidermal antigen-presenting cells by in vivo ultraviolet A, B, and C irradiation.
Baadsgaard O; Cooper KD; Lisby S; Wulf HC; Wantzin GL
J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):792-800. PubMed ID: 3500191
[TBL] [Abstract][Full Text] [Related]
19. T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens.
Tjernlund U; Scheynius A; Johansson C; Hagforsen E; Nilsson H
Scand J Immunol; 1988 Dec; 28(6):667-73. PubMed ID: 3266023
[TBL] [Abstract][Full Text] [Related]
20. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
Sontheimer RD
J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
